# TFS Financial CORP: financial statements, quarterly

TFSL · Nasdaq · CIK 1381668 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/tfsl.md) · [Financials](/companies/tfsl/financials.md) · [Filings](/companies/tfsl/filings.md) · [Insiders](/companies/tfsl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tfsl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [98.4 d](/filings/0001381668-23-000092.md) | [108](/filings/0001381668-24-000018.md) | [112](/filings/0001381668-24-000082.md) | [116](/filings/0001381668-24-000111.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.9 d](/filings/0001381668-25-000106.md) | [5.4](/filings/0001381668-25-000010.md) | [5.2](/filings/0001381668-25-000068.md) | [5.3](/filings/0001381668-25-000096.md) | [4.8 d](/filings/0001381668-25-000106.md) | [6.0](/filings/0001381668-26-000012.md) | [5.5](/filings/0001381668-26-000024.md) | [5.8](/filings/0001381668-26-000039.md) | [6.4 d](/filings/0001381668-25-000106.md) | [6.2](/filings/0001381668-26-000012.md) | [6.6](/filings/0001381668-26-000024.md) | [8.1](/filings/0001381668-26-000039.md) |
| Net income | $m | [19.5 d](/filings/0001381668-25-000106.md) | [20.7](/filings/0001381668-25-000010.md) | [20.7](/filings/0001381668-25-000068.md) | [20.0](/filings/0001381668-25-000096.md) | [18.2 d](/filings/0001381668-25-000106.md) | [22.4](/filings/0001381668-26-000012.md) | [21.0](/filings/0001381668-26-000024.md) | [21.5](/filings/0001381668-26-000039.md) | [26.0 d](/filings/0001381668-25-000106.md) | [22.3](/filings/0001381668-26-000012.md) | [23.2](/filings/0001381668-26-000024.md) | [30.5](/filings/0001381668-26-000039.md) |
| Diluted EPS | $ per share | not reported | [0.07](/filings/0001381668-25-000010.md) | [0.07](/filings/0001381668-25-000068.md) | [0.07](/filings/0001381668-25-000096.md) | not reported | [0.08](/filings/0001381668-26-000012.md) | [0.07](/filings/0001381668-26-000024.md) | [0.08](/filings/0001381668-26-000039.md) | not reported | [0.08](/filings/0001381668-26-000012.md) | [0.08](/filings/0001381668-26-000024.md) | [0.11](/filings/0001381668-26-000039.md) |
| Basic EPS | $ per share | not reported | [0.07](/filings/0001381668-25-000010.md) | [0.07](/filings/0001381668-25-000068.md) | [0.07](/filings/0001381668-25-000096.md) | not reported | [0.08](/filings/0001381668-26-000012.md) | [0.07](/filings/0001381668-26-000024.md) | [0.08](/filings/0001381668-26-000039.md) | not reported | [0.08](/filings/0001381668-26-000012.md) | [0.08](/filings/0001381668-26-000024.md) | [0.11](/filings/0001381668-26-000039.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001381668-24-000142.md) | [0.6](/filings/0001381668-24-000018.md) | [0.6](/filings/0001381668-24-000082.md) | [0.6](/filings/0001381668-24-000111.md) | [0.5](/filings/0001381668-25-000106.md) | [0.5](/filings/0001381668-25-000010.md) | [0.5](/filings/0001381668-25-000068.md) | [0.5](/filings/0001381668-25-000096.md) | [0.4](/filings/0001381668-26-000039.md) | [0.5](/filings/0001381668-26-000012.md) | [0.4](/filings/0001381668-26-000024.md) | [0.6](/filings/0001381668-26-000039.md) |
| Total assets | $bn | [16.9](/filings/0001381668-24-000142.md) | [17.1](/filings/0001381668-24-000018.md) | [17.0](/filings/0001381668-24-000082.md) | [17.0](/filings/0001381668-24-000111.md) | [17.1](/filings/0001381668-25-000106.md) | [17.1](/filings/0001381668-25-000010.md) | [17.1](/filings/0001381668-25-000068.md) | [17.4](/filings/0001381668-25-000096.md) | [17.5](/filings/0001381668-26-000039.md) | [17.5](/filings/0001381668-26-000012.md) | [17.5](/filings/0001381668-26-000024.md) | [18.1](/filings/0001381668-26-000039.md) |
| Total liabilities | $bn | [15.0](/filings/0001381668-24-000142.md) | [15.2](/filings/0001381668-24-000018.md) | [15.1](/filings/0001381668-24-000082.md) | [15.1](/filings/0001381668-24-000111.md) | [15.2](/filings/0001381668-25-000106.md) | [15.1](/filings/0001381668-25-000010.md) | [15.2](/filings/0001381668-25-000068.md) | [15.5](/filings/0001381668-25-000096.md) | [15.6](/filings/0001381668-26-000039.md) | [15.6](/filings/0001381668-26-000012.md) | [15.6](/filings/0001381668-26-000024.md) | [16.1](/filings/0001381668-26-000039.md) |
| Shareholders' equity | $bn | [1.9](/filings/0001381668-25-000106.md) | [1.9](/filings/0001381668-25-000068.md) | [1.9](/filings/0001381668-25-000096.md) | [1.9](/filings/0001381668-25-000096.md) | [1.9](/filings/0001381668-26-000039.md) | [1.9](/filings/0001381668-26-000024.md) | [1.9](/filings/0001381668-26-000039.md) | [1.9](/filings/0001381668-26-000039.md) | [1.9](/filings/0001381668-26-000039.md) | [1.9](/filings/0001381668-26-000024.md) | [1.9](/filings/0001381668-26-000039.md) | [2.0](/filings/0001381668-26-000039.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.8 d](/filings/0001381668-25-000106.md) | [36.3](/filings/0001381668-25-000010.md) | [14.2 d](/filings/0001381668-25-000068.md) | [96.7 d](/filings/0001381668-25-000096.md) | [(58.7) d](/filings/0001381668-25-000106.md) | [45.5](/filings/0001381668-26-000012.md) | [21.2 d](/filings/0001381668-26-000024.md) | [26.8 d](/filings/0001381668-26-000039.md) | [(11.1) d](/filings/0001381668-25-000106.md) | [58.7](/filings/0001381668-26-000012.md) | [17.6 d](/filings/0001381668-26-000024.md) | [32.5 d](/filings/0001381668-26-000039.md) |
| Capital expenditure | $m | [1.1 d](/filings/0001381668-25-000106.md) | [0.7](/filings/0001381668-25-000010.md) | [0.8 d](/filings/0001381668-25-000068.md) | [0.8 d](/filings/0001381668-25-000096.md) | [0.7 d](/filings/0001381668-25-000106.md) | [0.6](/filings/0001381668-26-000012.md) | [6.9 d](/filings/0001381668-26-000024.md) | [1.7 d](/filings/0001381668-26-000039.md) | [2.1 d](/filings/0001381668-25-000106.md) | [1.7](/filings/0001381668-26-000012.md) | [4.2 d](/filings/0001381668-26-000024.md) | [3.5 d](/filings/0001381668-26-000039.md) |
| Dividends paid | $m | [14.6 d](/filings/0001381668-25-000106.md) | [14.8](/filings/0001381668-25-000010.md) | [14.7 d](/filings/0001381668-25-000068.md) | [14.7 d](/filings/0001381668-25-000096.md) | [14.8 d](/filings/0001381668-25-000106.md) | [14.9](/filings/0001381668-26-000012.md) | [14.9 d](/filings/0001381668-26-000024.md) | [14.9 d](/filings/0001381668-26-000039.md) | [14.9 d](/filings/0001381668-25-000106.md) | [15.1](/filings/0001381668-26-000012.md) | [14.9 d](/filings/0001381668-26-000024.md) | [14.9 d](/filings/0001381668-26-000039.md) |
| Share repurchases | $m | [0.3 d](/filings/0001381668-25-000106.md) | [1.9](/filings/0001381668-25-000010.md) | [0.0 d](/filings/0001381668-25-000068.md) | [0.0 d](/filings/0001381668-25-000096.md) | [0.0 d](/filings/0001381668-25-000106.md) | [0.8](/filings/0001381668-26-000012.md) | [0.0 d](/filings/0001381668-26-000024.md) | [0.7 d](/filings/0001381668-26-000039.md) | [2.5 d](/filings/0001381668-25-000106.md) | [3.0](/filings/0001381668-26-000012.md) | [2.1 d](/filings/0001381668-26-000024.md) | [1.2 d](/filings/0001381668-26-000039.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [278](/filings/0001381668-24-000018.md) | [278](/filings/0001381668-24-000082.md) | [279](/filings/0001381668-24-000111.md) | [279](/filings/0001381668-25-000010.md) | [279](/filings/0001381668-25-000068.md) | [279](/filings/0001381668-25-000096.md) | [280](/filings/0001381668-26-000012.md) | [280](/filings/0001381668-26-000024.md) | [280](/filings/0001381668-26-000039.md) | [280](/filings/0001381668-26-000012.md) | [280](/filings/0001381668-26-000024.md) | [280](/filings/0001381668-26-000039.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 280,442,755 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001381668-26-000039.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.